| Literature DB >> 20676366 |
Xianyao Li1, Christina L Swaggerty, Michael H Kogut, Hsin-I Chiang, Ying Wang, Kenneth J Genovese, Haiqi He, Huaijun Zhou.
Abstract
Campylobacter jejuni (C. jejuni) is one of the most common causes of human bacterial enteritis worldwide primarily due to contaminated poultry products. Previously, we found a significant difference in C. jejuni colonization in the ceca between two genetically distinct broiler lines (Line A (resistant) has less colony than line B (susceptible) on day 7 post inoculation). We hypothesize that different mechanisms between these two genetic lines may affect their ability to resist C. jejuni colonization in chickens. The molecular mechanisms of the local host response to C. jejuni colonization in chickens have not been well understood. In the present study, to profile the cecal gene expression in the response to C. jejuni colonization and to compare differences between two lines at the molecular level, RNA of ceca from two genetic lines of chickens (A and B) were applied to a chicken whole genome microarray for a pair-comparison between inoculated (I) and non-inoculated (N) chickens within each line and between lines. Our results demonstrated that metabolism process and insulin receptor signaling pathways are key contributors to the different response to C. jejuni colonization between lines A and B. With C. jejuni inoculation, lymphocyte activation and lymphoid organ development functions are important for line A host defenses, while cell differentiation, communication and signaling pathways are important for line B. Interestingly, circadian rhythm appears play a critical role in host response of the more resistant A line to C. jejuni colonization. A dramatic differential host response was observed between these two lines of chickens. The more susceptible line B chickens responded to C. jejuni inoculation with a dramatic up-regulation in lipid, glucose, and amino acid metabolism, which is undoubtedly for use in the response to the colonization with little or no change in immune host defenses. However, in more resistant line A birds the host defense responses were characterized by an up-regulation lymphocyte activation, probably by regulatory T cells and an increased expression of the NLR recognition receptor NALP1. To our knowledge, this is the first time each of these responses has been observed in the avian response to an intestinal bacterial pathogen.Entities:
Mesh:
Year: 2010 PMID: 20676366 PMCID: PMC2911375 DOI: 10.1371/journal.pone.0011827
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Number of significantly differentially expressed genes between comparisons.
A: Number of genes with higher expression in one line (A or B) than the other line (B or A) when comparing between lines A and B. White bar represents number of genes with higher expression in line A than line B; Black bar represents number of genes with higher expression in line B than line A. B: Number of up and down-regulated genes following C. jejuni inoculation within each line (A or B) when comparing inoculated with non-inoculated control chickens. White bar represents number of up-regulated genes; Black bar represents number of down-regulated genes.
Figure 2Venn diagram showing the number of differentially expressed genes overlapped in different comparisons.
A: Number of genes overlapped between lines A and B of inoculated and non-inoculated birds. B: Number of genes overlapped between inoculated birds and non-inoculated within A line and B line.
Figure 3Enriched BP GO terms for significantly expressed genes between genetic lines.
A: Enriched GO terms in the comparison of AN/BN. Note: regulation of insulin receptor signal… represents regulation of insulin receptor signaling pathway. B: Enriched GO terms in the comparison of AI/BI. Note: transmembrane receptor protein tyrosine kinase signalin…represents transmembrane receptor protein tyrosine kinase signaling pathway.
Figure 4Enriched BP GO terms for significantly expressed genes between inoculated and non-inoculated birds within lines.
A: Enriched BP GO terms in the comparison of AI/AN. B: Enriched BP GO terms in the comparison of BI/BN. Note: embryonic development ending in birth or egg hat… represents embryonic development ending in birth or egg hatch; transmembrane receptor protein serine/threonie… represents transmembrane receptor protein serine/threonine kinase signaling pathway.
Fold-change of significantly differentially expressed immune-related genes between genetic lines in the microarray results (P<0.01).
| Accession No. | Gene description | AN/BN | AI/BI |
| AB025103 | Immunoglobulin J chain | −3.88 | |
| AB109024 | Complement receptor1 | 1.86 | 1.71 |
| AF424806 | Suppressor of cytokine signaling 3 (SOCS3) | −2.28 | −2.31 |
| AF498236 | Suppressor of cytokine signaling 2 (SOCS2) | −2.25 | |
| AJ720544 | Interleukin F2 | −2.04 | −1.77 |
| AJ720982 | Chemokine (C-Cmotif) receptor8 | −4.33 | −3.01 |
| AJ852017 | Interleukin -7 (IL7) | −3.42 | −1.85 |
| AY460177 | MRAS | −2.85 | |
| AY621314 | β -defensin12 | 3.59 | |
| BG625680 | Putative E-selectin | −1.79 | −1.54 |
| BU344261 | TANK-binding kinase 1 (TBK1) | −2.78 | |
| BU376898 | CD135 | −2.19 | −2.53 |
| BX931297 | Cytokine like protein 17 | 7.54 | |
| CF258095 | Chemokine-like ligand 1 | −1.57 | |
| CR352545 | Granulocyte-macrophage colony-stimulating factor | −1.64 | |
| CR388516 | β -defensin10 | 3.47 | |
| XM_415289 | NALP1 (LOC416998) | 3.30 | 2.16 |
| L18784 | Transforming growth factor, beta receptor II | 3.30 | |
| X67915 | Lymphocyte surface marker mammalian CD28 homologue (CHT28) | −4.41 | −2.80 |
| X71786 | Integrin beta 2 (ITGB2) | −2.35 | |
| Y14971 | CXC chemokine K60 (K60) | −2.02 | −2.09 |
| Y15006 | Interleukin-1beta (IL1b) | −3.51 | −3.10 |
| Z22726 | CD8 alpha | −3.91 | −4.03 |
| Z26484 | CD8 beta | −2.11 | −2.05 |
Fold-change of significantly differentially expressed immune-related genes between inoculated and non-inoculated chickens within lines in microarray results (P<0.01).
| Accession No. | Gene description | AI/AN | BI/BN |
| AB015289 | B cell adaptor containing SH2 domain | −1.17 | |
| AB109024 | Complement receptor1 | 1.26 | |
| AF074248 | Signal transducer and activator of transcription 5 | −1.20 | |
| AF335427 | Nuclear factor, interleukin 3 regulated | 1.36 | |
| AF424806 | Suppressor of cytokine signaling 3 (SOCS3) | −1.60 | −1.58 |
| AJ450829 | Chemokine receptor 5 (CXCR5) | −1.80 | |
| AJ719741 | CKLF-like MARVEL transmembrane domain containing 7 | −1.29 | −1.27 |
| AJ719814 | B cell antigen receptor associated protein | −1.39 | |
| AJ720236 | NCK adaptor protein 2 | 1.15 | |
| AJ720504 | Toll-like receptor 7 (TLR7) | −1.27 | |
| AJ720845 | RAS guanyl releasing protein 3 (calcium and DAG-regulated) | −1.35 | |
| AJ721122 | Mitogen-activated protein kinase kinase 5 (MAPKK5) | 1.18 | |
| AJ843261 | Transporter associated with antigen processing 1 (TAP1) | 1.28 | |
| AJ851659 | CD80 antigen | −1.22 | |
| AJ851740 | Ankyrin repeat and SOCS box-containing 7 | 1.35 | |
| AY566700 | Growth/differentiation factor-9 | 2.02 | |
| BU308587 | Heat-shock protein (HSP70) | 1.29 | |
| BX934914 | Interleukin 22 receptor alpha | 1.25 | |
| CK610423 | Chemokine ah221 (CCL11) | −2.00 | |
| CR338861 | CKLF-like MARVEL transmembrane domain containing 4 | 1.28 | |
| CR390308 | Glioma Amplified Sequence 41 | −1.42 | |
| CR406783 | Ficolin (collagen/fibrinogendomaincontaininglectin) 2 | −1.29 | −1.26 |
| CR523215 | Natural killer cell receptor 2B4 | −1.33 | |
| CR523828 | Suppressor of cytokine signaling 5 (SOCS5) | 1.18 | |
| D16367 | NFkB-2; Nuclear factor NF-kBp52/p100 | −1.27 | |
| DQ267901 | Toll- like receptor 15 (TLR15) | −1.43 | |
| XM_415289 | NALP1 (LOC416998) | 1.53 | |
| L06109 | Purinergic receptor P2Y, G-protein coupled 5 (P2RY5) | −1.18 | |
| M16199 | Interleukin 8 (IL8) | −1.92 | −1.95 |
| Y12011 | CD5 | −1.50 | |
| Y14971 | CXC chemokine K60 (K60) | −1.75 | −1.69 |
| Y15006 | Interleukin-1beta (IL1b) | −1.57 | −1.78 |
| Y18692 | Chemokine K203 (K203) | −1.46 |
Comparison of gene expression levels between microarray and qRT-PCR.
| Comparison | AI/AN | BI/BN | AN/BN | AI/BI | ||||
| MethodGenes | qRT-PCR | Micro-array | qRT-PCR | Micro-array | qRT-PCR | Micro-array | qRT-PCR | Micro-array |
| IL-1b | −2.03 | −1.57 | −2.21 | −1.78 | −3.77 | −3.51 | ||
| SOCS3 | −1.76 | −1.60 | −2.71 | −2.31 | ||||
| K60 | −2.21 | −1.69 | −2.26 | −2.02 | ||||
| IL-8 | −2.32 | −1.92 | ||||||
| GAL10 | 8.51 | 3.47 | ||||||
| CD5 | −1.92 | −1.50 | ||||||
| CD80 | 1.94 | −1.22 | ||||||
| STAT5B | −1.34 | −1.20 | ||||||
| GHRL | 3.80 | 2.08 | ||||||
| CLOCK | 1.72 | 1.29 | 1.66 | 1.40 | ||||
Note: Fold-change was listed in the table.
*represents the gene significantly differentially expressed in the comparison (P<0.05 in RT-PCR result, P<0.005 in microarray).